You are here: Home » PTI Stories » National » News
Business Standard

Lupin launches testosterone gel in US

Press Trust of India  |  New Delhi 

Drug firm Friday announced the launch of gel, used for treating low or no in men due to certain medical conditions, in the US market.

Lupin's gel, 1.62 per cent (20.25 mg/1.25 g pump actuation), is the generic equivalent of AbbVie Inc's AndroGel, 1.62 per cent, said in a BSE filing.

Quoting IQVIA MAT December 2018 data, said AndroGel had annual sales of around USD 893 million in the US market.

On Thursday Lupin had said that it has received the nod from the Food and Drug Administration (USFDA) to market its testosterone gel.

Shares of Lupin were trading 2.44 per cent higher at Rs 825.55 apiece on BSE.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Fri, April 12 2019. 12:00 IST